892
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Reduction in myocardial function and oxygen consumption after chemoradiotherapy in patients with esophageal cancer

, , , & ORCID Icon
Pages 566-574 | Received 30 Nov 2021, Accepted 25 Feb 2022, Published online: 15 Mar 2022

References

  • Shapiro J, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–1098.
  • Witt JS, Jagodinsky JC, Liu Y, et al. Cardiac toxicity in operable esophageal cancer patients treated with or without chemoradiation. Am J Clin Oncol. 2019;42(8):662–667.
  • Yusuf SW, Venkatesulu BP, Mahadevan LS, et al. Radiation-induced cardiovascular disease: a clinical perspective. Front Cardiovasc Med. 2017;4:66.
  • Lund M, Alexandersson von Döbeln G, Nilsson M, et al. Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction – a prospective cohort pilot study within a randomized clinical trial. Radiat Oncol. 2015;10:16.
  • Søndergaard MMA, Nordsmark M, Nielsen KM, et al. Cardiovascular burden and adverse events in patients with esophageal cancer treated with chemoradiation for curative intent. JACC CardioOncol. 2021;3:711–721.
  • Tops LF, Delgado V, Marsan NA, et al. Myocardial strain to detect subtle left ventricular systolic dysfunction. Eur J Heart Fail. 2017;19(3):307–313.
  • Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751–2768.
  • Patel J, Rikhi R, Hussain M, et al. Global longitudinal strain is a better metric than left ventricular ejection fraction: lessons learned from cancer therapeutic-related cardiac dysfunction. Curr Opin Cardiol. 2020;35(2):170–177.
  • Larsen AH, Clemmensen TS, Wiggers H, et al. Left ventricular myocardial contractile reserve during exercise stress in healthy adults: a two-dimensional speckle-tracking echocardiographic study. J Am Soc Echocardiogr. 2018;31(10):1116–1126.e1.
  • Clemmensen TS, Løgstrup BB, Eiskjaer H, et al. Coronary flow reserve predicts longitudinal myocardial deformation capacity in heart-transplanted patients. Echocardiography. 2016;33(4):562–571.
  • Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(2):101–138.
  • Chiappa A, Andreoni B, Dionigi R, et al. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: accurate review of management and perspectives. Crit Rev Oncol Hematol. 2018;132:161–168.
  • Bredy C, Ministeri M, Kempny A, et al. New York heart association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. Eur Heart J Qual Care Clin Outcomes. 2018;4(1):51–58.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Searle SD, Mitnitski A, Gahbauer EA, et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.
  • Smiseth OA, Torp H, Opdahl A, et al. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37(15):1196–1207.
  • Okuhara Y, Asakura M, Orihara Y, et al. Reduction in left ventricular ejection fraction is associated with subsequent cardiac events in outpatients with chronic heart failure. Sci Rep. 2019;9(1):17271.
  • Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360.
  • Nyeng TB, Nordsmark M, Hoffmann L. Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients. Acta Oncol. 2015;54(9):1467–1473.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.
  • Collier P, Phelan D, Klein A. A test in context: myocardial strain measured by speckle-tracking echocardiography. J Am Coll Cardiol. 2017;69(8):1043–1056.
  • Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.
  • McDonagh TA, Metra M, Adamo M, et al. Corrigendum to: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2021;42(48):4901.
  • Badran HM, Faheem N, Ibrahim WA, et al. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension. J Am Soc Echocardiogr. 2013;26(12):1397–1406.
  • Paraskevaidis IA, Ikonomidis I, Simitsis P, et al. Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study. Eur J Heart Fail. 2017;19(7):846–861.
  • von Döbeln GA, Nilsson M, Adell G, et al. Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer. Pract Radiat Oncol. 2016;6(3):e53–e9.
  • Hayashi Y, Iijima H, Isohashi F, et al. The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study. BMC Cancer. 2019;19(1):195.
  • Beukema JC, van Luijk P, Widder J, et al. Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol. 2015;114(1):85–90.
  • Lin SH, Hobbs BP, Verma V, et al. Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol. 2020;38(14):1569–1579.
  • Møller DS, Poulsen PR, Hagner A, et al. Strategies for motion robust proton therapy with pencil beam scanning for esophageal cancer. Int J Radiat Oncol Biol Phys. 2021;111(2):539–548.
  • Chuong MD, Hallemeier CL, Jabbour SK, et al. Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys. 2016;95(1):488–497.
  • Delman AM, Ammann AM, Turner KM, et al. A narrative review of socioeconomic disparities in the treatment of esophageal cancer. J Thorac Dis. 2021;13(6):3801–3808.
  • Nordsmark M, Offersen BV. The risk of radiation-associated heart disease comes from many factors; the chain is as strong as the weakest link. Radiother Oncol. 2020;152:101–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.